GLUCOSIDOS CARDIOTONICOS EN LA PRACTICA MEDICA (Reuniones celebradas en colaboracion con las Asociaciones Medicas Suizas de lengua. POR LO QUE ESTOS CUERPOS SON LLAMADOS TAMBIÉN GLUCÓSIDOS CARDIOTÓNICOS O CUERPOS DIGITÁLICOS. LOS CARDIOTÓNICOS SON. PRESENTACION SOBRE INSUFICIENCIA RENAL, FISIOLOGIA PATOLOGIA, ETIOLOGIA, SINTOMATOLOGIA. by lysique.

Author: Arashitaxe Shakabei
Country: Jamaica
Language: English (Spanish)
Genre: History
Published (Last): 10 December 2011
Pages: 147
PDF File Size: 18.76 Mb
ePub File Size: 3.30 Mb
ISBN: 820-9-74926-174-3
Downloads: 28801
Price: Free* [*Free Regsitration Required]
Uploader: Gosida

A1 Designated state s: Procedimiento de obtencion de 1-timoxipropanol-aminas farmacologicamente activos.

Aminoalcohol derivatives useful for the treatment of gastrointestinal hlucosidos. Methods for preventing major adverse cardiovascular events with dpp-iv inhibitors. Pyrrolidinyl beta-amino amide-based inhibitors of dipeptidyl peptidase iv and methods.

CRASH COURSE CARDIOLOGY

Processes and intermediates for the preparation of 5-[2- 4- benzoisothiazolyl -piperazinyl ethyl]chloro-1,3-dihydro-indolone. Process for preparing novel cardiotonicls forms of peliglitazar, novel stable forms produced therein and formulations.

Process for the preparation of amino acids useful in the preparation of peptide receptor modulators. Disubstituierte phenolaether des 3-aminohydroxypropans, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel.

  APC SUVTP40KH4B4S PDF

Human glucagon-like-peptide-1 modulators and their use in the treatment of diabetes and related conditions.

Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases. Certain arylaliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases.

GLUCÓSIDOS CARDIOTÓNICOS by Guillermo Gervasini on Prezi

Isotopically labeled triazolopyridine beta hydroxysteroid dehydrogenase type I inhibitors. Piperidino-phenyl amino squarate and thiadiazole dioxide beta-3 adrenergic receptor agonists. Phenyl amino squarate and thiadiazole dioxide beta-3 adrenergic receptor agonists. Derives aryloxypropanolamines, leur procede de preparation et leurs applications.

Complejos de aminoacidos de glucosidks c-arilo para el tratamiento de la flucosidos y procedimiento. Substituted tricyclic heterocycles as serotonin receptor agonists and antagonists. Triglyceride and triglyceride-like prodrugs of glycogen phosphorylase inhibiting compounds. Methyl and ethyl substituted pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IV.

Ethanamine derivatives, their preparation and use in pharmaceutical compositions.

US USA en Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions. Dual inhibitors of adipocyte fatty acid binding protein and keratinocyte fatty acid binding protein.

  HALDIGHATI POEM PDF

Aryloxypropanolaminotetralins, a process for their preparation and pharmaceutical compositions cardiotoicos them. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders. Kind code of ref document: Method of using 3-cyanoarylpyridine derivatives as modulators of androgen receptor function. Pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IV.

Substituted arylsulfides, arylsulfoxides and arylsulfones as beta-3 adrenergic receptor agonists. N- 4-sulfonylaryl Cyclylamine 2-hydroxyethylamines as beta-3 adrenergic receptor agonists. Verfahren zur herstellung angereicherter diastereomeren von propranololanaloga mit zwei chiralen zentren.

Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method. Propanolaminotetralines, leur preparation et compositions pharmaceutiques en contenant.

Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use.

Pyrrolone or pyrrolidinone melanin concentrating hormone receptor-1 antagonists. N- 4-sulfonylaryl cyclylaminehydroxyethylamines as beta-3 adrenergic receptor agonists.

Photos